

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.27390776 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 8.24715474 |
| 3 | glomerular filtration (GO:0003094) | 7.23148076 |
| 4 | renal filtration (GO:0097205) | 6.55028934 |
| 5 | signal peptide processing (GO:0006465) | 5.97943857 |
| 6 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.96883651 |
| 7 | negative regulation of glucose import (GO:0046325) | 5.49902732 |
| 8 | regulation of respiratory burst (GO:0060263) | 5.42855940 |
| 9 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.12515637 |
| 10 | antimicrobial humoral response (GO:0019730) | 5.10932953 |
| 11 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.94288210 |
| 12 | phenylpropanoid metabolic process (GO:0009698) | 4.82266172 |
| 13 | Fc receptor signaling pathway (GO:0038093) | 4.79690018 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.52930053 |
| 15 | regulation of cellular extravasation (GO:0002691) | 4.52065284 |
| 16 | negative regulation of glucose transport (GO:0010829) | 4.44346321 |
| 17 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.40882022 |
| 18 | negative regulation of B cell proliferation (GO:0030889) | 4.25901194 |
| 19 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.23319467 |
| 20 | cellular response to zinc ion (GO:0071294) | 3.91117843 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.86349849 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.82916847 |
| 23 | detection of bacterium (GO:0016045) | 3.81621199 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.74452085 |
| 25 | detection of other organism (GO:0098543) | 3.73944093 |
| 26 | immune response-activating signal transduction (GO:0002757) | 3.73100148 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.58396967 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.51747539 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51747539 |
| 30 | regulation of B cell proliferation (GO:0030888) | 3.50861706 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.48861010 |
| 32 | regulation of antigen processing and presentation (GO:0002577) | 3.47938479 |
| 33 | germinal center formation (GO:0002467) | 3.45333352 |
| 34 | activation of immune response (GO:0002253) | 3.40420785 |
| 35 | angiotensin maturation (GO:0002003) | 3.39303420 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.38331051 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.38331051 |
| 38 | response to type I interferon (GO:0034340) | 3.36359412 |
| 39 | doxorubicin metabolic process (GO:0044598) | 3.27131652 |
| 40 | daunorubicin metabolic process (GO:0044597) | 3.27131652 |
| 41 | polyketide metabolic process (GO:0030638) | 3.27131652 |
| 42 | positive regulation of macrophage cytokine production (GO:0060907) | 3.24721964 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22860849 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21967006 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.21528911 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.18946017 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18775468 |
| 48 | negative regulation of myotube differentiation (GO:0010832) | 3.14932779 |
| 49 | fucose catabolic process (GO:0019317) | 3.14697707 |
| 50 | L-fucose metabolic process (GO:0042354) | 3.14697707 |
| 51 | L-fucose catabolic process (GO:0042355) | 3.14697707 |
| 52 | positive regulation of pseudopodium assembly (GO:0031274) | 3.10444684 |
| 53 | cellular response to interferon-gamma (GO:0071346) | 3.02825371 |
| 54 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.01320875 |
| 55 | complement activation, classical pathway (GO:0006958) | 27.8863402 |
| 56 | complement activation (GO:0006956) | 21.3886697 |
| 57 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.96421696 |
| 58 | surfactant homeostasis (GO:0043129) | 2.94274104 |
| 59 | chronic inflammatory response (GO:0002544) | 2.91797571 |
| 60 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.90939039 |
| 61 | B cell mediated immunity (GO:0019724) | 2.89477673 |
| 62 | NIK/NF-kappaB signaling (GO:0038061) | 2.87346840 |
| 63 | T-helper 1 type immune response (GO:0042088) | 2.84095063 |
| 64 | response to interferon-gamma (GO:0034341) | 2.82477253 |
| 65 | peptide catabolic process (GO:0043171) | 2.82074596 |
| 66 | detection of external biotic stimulus (GO:0098581) | 2.81924898 |
| 67 | production of molecular mediator of immune response (GO:0002440) | 2.81660948 |
| 68 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.80527718 |
| 69 | xenobiotic catabolic process (GO:0042178) | 2.79912697 |
| 70 | positive regulation of immunoglobulin production (GO:0002639) | 2.79662033 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78685708 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78685708 |
| 73 | cofactor catabolic process (GO:0051187) | 2.78006788 |
| 74 | proline biosynthetic process (GO:0006561) | 2.77799896 |
| 75 | mast cell activation (GO:0045576) | 2.76043874 |
| 76 | regulation of pseudopodium assembly (GO:0031272) | 2.75522441 |
| 77 | regulation of integrin activation (GO:0033623) | 2.73540902 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72806986 |
| 79 | dendritic cell chemotaxis (GO:0002407) | 2.71706019 |
| 80 | virion attachment to host cell (GO:0019062) | 2.69640024 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 2.69640024 |
| 82 | eosinophil chemotaxis (GO:0048245) | 2.67601711 |
| 83 | B cell proliferation (GO:0042100) | 2.64890267 |
| 84 | tissue homeostasis (GO:0001894) | 2.63951583 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.62708811 |
| 86 | intestinal absorption (GO:0050892) | 2.61222999 |
| 87 | T cell costimulation (GO:0031295) | 2.58117419 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 2.55459063 |
| 89 | protein-chromophore linkage (GO:0018298) | 2.54751787 |
| 90 | lymphocyte costimulation (GO:0031294) | 2.54192239 |
| 91 | regulation of necrotic cell death (GO:0010939) | 2.52910043 |
| 92 | negative regulation of B cell activation (GO:0050869) | 2.52164940 |
| 93 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.51533639 |
| 94 | respiratory burst (GO:0045730) | 2.50556545 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47639817 |
| 96 | negative regulation of humoral immune response (GO:0002921) | 2.47122124 |
| 97 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45535451 |
| 98 | oligosaccharide biosynthetic process (GO:0009312) | 2.45332702 |
| 99 | negative regulation of complement activation (GO:0045916) | 2.45164604 |
| 100 | eosinophil migration (GO:0072677) | 2.43751516 |
| 101 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42275663 |
| 102 | myeloid dendritic cell activation (GO:0001773) | 2.39446990 |
| 103 | regulation of vitamin metabolic process (GO:0030656) | 2.38266738 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38085794 |
| 105 | interferon-gamma secretion (GO:0072643) | 2.38072010 |
| 106 | negative regulation of bone resorption (GO:0045779) | 2.37531185 |
| 107 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35711397 |
| 108 | modulation by symbiont of host defense response (GO:0052031) | 2.35711397 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35711397 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35711397 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35711397 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.35711397 |
| 113 | regulation of B cell activation (GO:0050864) | 2.35665817 |
| 114 | dendritic cell migration (GO:0036336) | 2.35533709 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.35360319 |
| 116 | detection of biotic stimulus (GO:0009595) | 2.35311035 |
| 117 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.34668965 |
| 118 | I-kappaB phosphorylation (GO:0007252) | 2.34139142 |
| 119 | positive thymic T cell selection (GO:0045059) | 2.33885038 |
| 120 | defense response to protozoan (GO:0042832) | 2.32787423 |
| 121 | regulation of regulatory T cell differentiation (GO:0045589) | 2.30428621 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.29958354 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.29121453 |
| 124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.27090297 |
| 125 | L-phenylalanine catabolic process (GO:0006559) | 2.27090297 |
| 126 | positive regulation of interleukin-4 production (GO:0032753) | 2.26226157 |
| 127 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.22818518 |
| 128 | COPI coating of Golgi vesicle (GO:0048205) | 2.20704300 |
| 129 | Golgi transport vesicle coating (GO:0048200) | 2.20704300 |
| 130 | benzene-containing compound metabolic process (GO:0042537) | 2.15952299 |
| 131 | negative regulation of interleukin-10 production (GO:0032693) | 2.15797460 |
| 132 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.14466859 |
| 133 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.11428420 |
| 134 | coenzyme catabolic process (GO:0009109) | 2.11295823 |
| 135 | regulation of macrophage cytokine production (GO:0010935) | 2.11123550 |
| 136 | mast cell degranulation (GO:0043303) | 2.09482435 |
| 137 | mast cell activation involved in immune response (GO:0002279) | 2.09482435 |
| 138 | positive regulation of Rap GTPase activity (GO:0032854) | 2.04223808 |
| 139 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.04050990 |
| 140 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.03884436 |
| 141 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.03032590 |
| 142 | locomotory exploration behavior (GO:0035641) | 2.00852823 |
| 143 | negative thymic T cell selection (GO:0045060) | 2.00787942 |
| 144 | protein activation cascade (GO:0072376) | 13.9304290 |
| 145 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.4026669 |
| 146 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.4026669 |
| 147 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.4026669 |
| 148 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.2763990 |
| 149 | retina homeostasis (GO:0001895) | 10.7491647 |
| 150 | protein N-linked glycosylation via asparagine (GO:0018279) | 1.99792560 |
| 151 | primary alcohol catabolic process (GO:0034310) | 1.99545752 |
| 152 | antigen receptor-mediated signaling pathway (GO:0050851) | 1.99108784 |
| 153 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 1.98872501 |
| 154 | aldehyde catabolic process (GO:0046185) | 1.98792705 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 1.97991659 |
| 156 | regulation of immunoglobulin production (GO:0002637) | 1.97949765 |
| 157 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.95829459 |
| 158 | N-glycan processing (GO:0006491) | 1.94967428 |
| 159 | protein maturation by protein folding (GO:0022417) | 1.94590091 |
| 160 | peptidyl-asparagine modification (GO:0018196) | 1.93761236 |
| 161 | T cell lineage commitment (GO:0002360) | 1.93752196 |
| 162 | production of molecular mediator involved in inflammatory response (GO:0002532) | 1.92215549 |
| 163 | L-phenylalanine metabolic process (GO:0006558) | 1.90373403 |
| 164 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 1.90373403 |
| 165 | aromatic amino acid family catabolic process (GO:0009074) | 1.90259610 |
| 166 | neutrophil activation involved in immune response (GO:0002283) | 1.89891110 |
| 167 | glutamine family amino acid biosynthetic process (GO:0009084) | 1.86788867 |
| 168 | mature B cell differentiation (GO:0002335) | 1.86577740 |
| 169 | antibacterial humoral response (GO:0019731) | 1.86429908 |
| 170 | protein N-linked glycosylation (GO:0006487) | 1.84480222 |
| 171 | maternal placenta development (GO:0001893) | 1.84306676 |
| 172 | opsonization (GO:0008228) | 1.84059276 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.84020063 |
| 174 | positive regulation of Rho protein signal transduction (GO:0035025) | 1.83854149 |
| 175 | proline metabolic process (GO:0006560) | 1.80522993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.75453744 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.90320193 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.62858973 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.48596736 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.30626913 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.16224822 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.81881475 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.69225660 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.49012299 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.21328026 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.20327464 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.19484612 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 3.06405565 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.94125407 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82616819 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.82374711 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.73019871 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.67051540 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.66797457 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63653056 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56979666 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.42464703 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26890408 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.21152686 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.18680479 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12573146 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.05722606 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03834867 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02559789 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01755242 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.97244069 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97001080 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.92153461 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91067150 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86870388 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85472633 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85393133 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84819296 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83617777 |
| 40 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.82203980 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77804393 |
| 42 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.75038009 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74802641 |
| 44 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.73007298 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72780634 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69884929 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67093872 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65411373 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62569007 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61797649 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.60613343 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60126437 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58416926 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56869484 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55412028 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54190806 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53984428 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51247571 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49991944 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.49071575 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39402999 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38506984 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37411125 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37228865 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36083526 |
| 66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35518064 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35125028 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33687234 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31308666 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29318406 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26637333 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26226796 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26082326 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26037294 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25499060 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24228784 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.23717550 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20301073 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20286725 |
| 80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18893780 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17913304 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17536155 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16015454 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15029270 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14999936 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14158107 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13952819 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13742267 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13591776 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12714559 |
| 91 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.12543827 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12362376 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10287030 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09663071 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08968406 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08388108 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07479383 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07446088 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07404195 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07404195 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07051372 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06272542 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05814690 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04795529 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04449836 |
| 106 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04032429 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01865027 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01654726 |
| 109 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97901007 |
| 110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97638354 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96599954 |
| 112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95708561 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94947365 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94129223 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93770802 |
| 116 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93446820 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93178173 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92274706 |
| 119 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.89260958 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88299524 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88044576 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88042198 |
| 123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87991693 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87764888 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87713770 |
| 126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87246529 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86619678 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86137857 |
| 129 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85562590 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85044242 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83401194 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82965731 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82755518 |
| 134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81303254 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79143088 |
| 136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78920514 |
| 137 | MAF_26560356_Chip-Seq_TH2_Human | 0.78854819 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78819135 |
| 139 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77731419 |
| 140 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77518261 |
| 141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77428212 |
| 142 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77049914 |
| 143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76863269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.77150752 |
| 2 | MP0001800_abnormal_humoral_immune | 4.15219536 |
| 3 | MP0003724_increased_susceptibility_to | 4.14774907 |
| 4 | MP0003303_peritoneal_inflammation | 3.71112054 |
| 5 | MP0005671_abnormal_response_to | 3.69748780 |
| 6 | MP0001790_abnormal_immune_system | 3.13759897 |
| 7 | MP0005387_immune_system_phenotype | 3.13759897 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.95934439 |
| 9 | MP0006054_spinal_hemorrhage | 2.75068672 |
| 10 | MP0002723_abnormal_immune_serum | 2.64132604 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.59404607 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.40428239 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.38642900 |
| 14 | MP0005360_urolithiasis | 2.36630415 |
| 15 | MP0001819_abnormal_immune_cell | 2.32436111 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.30865958 |
| 17 | MP0000920_abnormal_myelination | 2.18651259 |
| 18 | MP0002398_abnormal_bone_marrow | 2.18596694 |
| 19 | MP0000716_abnormal_immune_system | 2.18199660 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.16968099 |
| 21 | MP0001873_stomach_inflammation | 2.14331248 |
| 22 | MP0005166_decreased_susceptibility_to | 2.11014819 |
| 23 | MP0000685_abnormal_immune_system | 2.06184094 |
| 24 | MP0005275_abnormal_skin_tensile | 2.00425046 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.96996395 |
| 26 | MP0005025_abnormal_response_to | 1.96956685 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.96315103 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.94144104 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.91223534 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.90802870 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.90471125 |
| 32 | MP0002419_abnormal_innate_immunity | 1.85055488 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.84222049 |
| 34 | MP0002429_abnormal_blood_cell | 1.75487148 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.74834812 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.66899863 |
| 37 | MP0004147_increased_porphyrin_level | 1.59055087 |
| 38 | MP0008004_abnormal_stomach_pH | 1.54049089 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.51848868 |
| 40 | MP0002722_abnormal_immune_system | 1.51758368 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.50173745 |
| 42 | MP0004947_skin_inflammation | 1.49552506 |
| 43 | MP0004858_abnormal_nervous_system | 1.48829363 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.47936110 |
| 45 | MP0009785_altered_susceptibility_to | 1.47666554 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.47470829 |
| 47 | MP0002006_tumorigenesis | 1.46786318 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.46221017 |
| 49 | MP0003690_abnormal_glial_cell | 1.45485503 |
| 50 | MP0003880_abnormal_central_pattern | 1.44537524 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.37566350 |
| 52 | MP0003448_altered_tumor_morphology | 1.37262472 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.34423031 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.29967741 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29631820 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 1.28755596 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.27324752 |
| 58 | MP0005023_abnormal_wound_healing | 1.26997001 |
| 59 | MP0003075_altered_response_to | 1.25692053 |
| 60 | MP0003045_fibrosis | 1.24578596 |
| 61 | MP0005503_abnormal_tendon_morphology | 1.24552925 |
| 62 | MP0003436_decreased_susceptibility_to | 1.22877404 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.22558527 |
| 64 | MP0005083_abnormal_biliary_tract | 1.22163918 |
| 65 | MP0002405_respiratory_system_inflammati | 1.21809665 |
| 66 | MP0005381_digestive/alimentary_phenotyp | 1.20779628 |
| 67 | MP0002796_impaired_skin_barrier | 1.20697379 |
| 68 | MP0000490_abnormal_crypts_of | 1.20260114 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.18021976 |
| 70 | MP0000477_abnormal_intestine_morphology | 1.17882972 |
| 71 | MP0005310_abnormal_salivary_gland | 1.16907813 |
| 72 | MP0009046_muscle_twitch | 1.14695438 |
| 73 | MP0003329_amyloid_beta_deposits | 1.13699016 |
| 74 | MP0008569_lethality_at_weaning | 1.13617841 |
| 75 | MP0000858_altered_metastatic_potential | 1.11439170 |
| 76 | MP0000343_altered_response_to | 1.10074251 |
| 77 | MP0002933_joint_inflammation | 1.08721782 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.08024558 |
| 79 | MP0009840_abnormal_foam_cell | 1.07536611 |
| 80 | MP0000604_amyloidosis | 1.05638189 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05535339 |
| 82 | MP0006082_CNS_inflammation | 1.04634841 |
| 83 | MP0003279_aneurysm | 1.04329636 |
| 84 | MP0005332_abnormal_amino_acid | 1.03971706 |
| 85 | MP0001664_abnormal_digestion | 1.03472848 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 1.03363772 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 1.03362069 |
| 88 | MP0002272_abnormal_nervous_system | 1.02457146 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.02203725 |
| 90 | MP0005390_skeleton_phenotype | 0.98702527 |
| 91 | MP0004885_abnormal_endolymph | 0.95639285 |
| 92 | MP0003091_abnormal_cell_migration | 0.95572821 |
| 93 | MP0003866_abnormal_defecation | 0.95299904 |
| 94 | MP0001958_emphysema | 0.94895128 |
| 95 | MP0001851_eye_inflammation | 0.94861836 |
| 96 | MP0008469_abnormal_protein_level | 0.93420837 |
| 97 | MP0005365_abnormal_bile_salt | 0.92525158 |
| 98 | MP0000249_abnormal_blood_vessel | 0.91887744 |
| 99 | MP0005409_darkened_coat_color | 0.91531095 |
| 100 | MP0003868_abnormal_feces_composition | 0.91383136 |
| 101 | MP0005164_abnormal_response_to | 0.91267349 |
| 102 | MP0005388_respiratory_system_phenotype | 0.90416714 |
| 103 | MP0002133_abnormal_respiratory_system | 0.90416714 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.90275339 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.90161069 |
| 106 | MP0002064_seizures | 0.90052333 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.87987439 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.87002600 |
| 109 | MP0001905_abnormal_dopamine_level | 0.86820118 |
| 110 | MP0001853_heart_inflammation | 0.86284669 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.85184536 |
| 112 | MP0001666_abnormal_nutrient_absorption | 0.84464352 |
| 113 | MP0004142_abnormal_muscle_tone | 0.83506093 |
| 114 | MP0003806_abnormal_nucleotide_metabolis | 0.82857649 |
| 115 | MP0005165_increased_susceptibility_to | 0.82823013 |
| 116 | MP0002736_abnormal_nociception_after | 0.82739961 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.81832723 |
| 118 | MP0005451_abnormal_body_composition | 0.81309792 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.81268975 |
| 120 | MP0003633_abnormal_nervous_system | 0.81152401 |
| 121 | MP0002277_abnormal_respiratory_mucosa | 0.80239782 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.79521161 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.79320902 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.78158775 |
| 125 | MP0003795_abnormal_bone_structure | 0.78073186 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.77636710 |
| 127 | MP0003635_abnormal_synaptic_transmissio | 0.76431594 |
| 128 | MP0001529_abnormal_vocalization | 0.75816519 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.75219869 |
| 130 | MP0004134_abnormal_chest_morphology | 0.74657127 |
| 131 | MP0000609_abnormal_liver_physiology | 0.73629740 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.73221717 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.73221717 |
| 134 | MP0001177_atelectasis | 0.73009669 |
| 135 | MP0008872_abnormal_physiological_respon | 0.72261706 |
| 136 | MP0003828_pulmonary_edema | 0.71368214 |
| 137 | MP0004510_myositis | 0.70185137 |
| 138 | MP0009764_decreased_sensitivity_to | 0.69441342 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.69185388 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.68933139 |
| 141 | MP0005535_abnormal_body_temperature | 0.68907775 |
| 142 | MP0001663_abnormal_digestive_system | 0.68546262 |
| 143 | MP0003186_abnormal_redox_activity | 0.68523843 |
| 144 | MP0002873_normal_phenotype | 0.68070231 |
| 145 | MP0002169_no_abnormal_phenotype | 0.67173564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 7.69360870 |
| 2 | Abnormality of B cell number (HP:0010975) | 7.69360870 |
| 3 | Agammaglobulinemia (HP:0004432) | 7.00703433 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.99176768 |
| 5 | Recurrent sinusitis (HP:0011108) | 5.61791888 |
| 6 | Recurrent bronchitis (HP:0002837) | 5.46233745 |
| 7 | Prostate neoplasm (HP:0100787) | 5.25984145 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 4.92198183 |
| 9 | Cellulitis (HP:0100658) | 4.89973870 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.69318301 |
| 11 | Verrucae (HP:0200043) | 4.39417649 |
| 12 | Papilloma (HP:0012740) | 4.39417649 |
| 13 | IgM deficiency (HP:0002850) | 4.28444144 |
| 14 | Malnutrition (HP:0004395) | 4.26568607 |
| 15 | Thyroiditis (HP:0100646) | 4.02360801 |
| 16 | Meningitis (HP:0001287) | 4.00269494 |
| 17 | Abnormality of complement system (HP:0005339) | 3.93938356 |
| 18 | Abnormality of the prostate (HP:0008775) | 3.87587152 |
| 19 | Recurrent viral infections (HP:0004429) | 3.85906893 |
| 20 | Recurrent pneumonia (HP:0006532) | 3.82109032 |
| 21 | Colitis (HP:0002583) | 3.79882739 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.69690843 |
| 23 | Glomerulonephritis (HP:0000099) | 3.66601578 |
| 24 | Complement deficiency (HP:0004431) | 3.63644934 |
| 25 | Hypoplasia of the thymus (HP:0000778) | 3.56362379 |
| 26 | Chronic otitis media (HP:0000389) | 3.55445796 |
| 27 | Hyperactive renin-angiotensin system (HP:0000841) | 3.34670344 |
| 28 | Chronic sinusitis (HP:0011109) | 3.33691944 |
| 29 | Mitral stenosis (HP:0001718) | 3.27907661 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 3.17106267 |
| 31 | Acute encephalopathy (HP:0006846) | 3.13092498 |
| 32 | Nephritis (HP:0000123) | 3.08277781 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.08122353 |
| 34 | Increased IgE level (HP:0003212) | 3.07751129 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.07699621 |
| 36 | Premature loss of primary teeth (HP:0006323) | 3.07320954 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.06269140 |
| 38 | Chronic diarrhea (HP:0002028) | 3.02086276 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99987131 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.94888159 |
| 41 | Recurrent lower respiratory tract infections (HP:0002783) | 2.94008014 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.93253892 |
| 43 | Osteomyelitis (HP:0002754) | 2.93083403 |
| 44 | Bronchitis (HP:0012387) | 2.91859146 |
| 45 | Sepsis (HP:0100806) | 2.83528200 |
| 46 | IgG deficiency (HP:0004315) | 2.80844266 |
| 47 | Gingivitis (HP:0000230) | 2.79374328 |
| 48 | Recurrent otitis media (HP:0000403) | 2.77301802 |
| 49 | Leukocytosis (HP:0001974) | 2.76744539 |
| 50 | Myositis (HP:0100614) | 2.76616601 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.76597071 |
| 52 | Urticaria (HP:0001025) | 2.66303182 |
| 53 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.65480396 |
| 54 | Villous atrophy (HP:0011473) | 2.65480396 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.63219281 |
| 56 | Skin rash (HP:0000988) | 2.61819809 |
| 57 | Leukodystrophy (HP:0002415) | 2.59186807 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.58814379 |
| 59 | Alopecia of scalp (HP:0002293) | 2.58299378 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57638096 |
| 61 | Emphysema (HP:0002097) | 2.57079554 |
| 62 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55108156 |
| 63 | Restrictive lung disease (HP:0002091) | 2.54485756 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.54054183 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.52730211 |
| 66 | Hyperventilation (HP:0002883) | 2.49081927 |
| 67 | Hemoptysis (HP:0002105) | 2.46445574 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.46279920 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45945984 |
| 70 | Decreased circulating renin level (HP:0003351) | 2.45742076 |
| 71 | Hypoproteinemia (HP:0003075) | 2.45110001 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.44523838 |
| 73 | T lymphocytopenia (HP:0005403) | 2.43021712 |
| 74 | Acrocyanosis (HP:0001063) | 2.42379099 |
| 75 | Mucosal telangiectasiae (HP:0100579) | 2.41814362 |
| 76 | Vasculitis (HP:0002633) | 2.41438041 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.41235894 |
| 78 | Recurrent abscess formation (HP:0002722) | 2.39992601 |
| 79 | Xerostomia (HP:0000217) | 2.37816845 |
| 80 | Orchitis (HP:0100796) | 2.37756691 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.35183492 |
| 82 | Nonimmune hydrops fetalis (HP:0001790) | 2.29528036 |
| 83 | Abnormality of T cells (HP:0002843) | 2.29389108 |
| 84 | Combined immunodeficiency (HP:0005387) | 2.29351668 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.26556589 |
| 86 | Abnormality of male internal genitalia (HP:0000022) | 2.25909661 |
| 87 | Conjunctival hamartoma (HP:0100780) | 2.25365251 |
| 88 | Obstructive lung disease (HP:0006536) | 2.24667178 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24667178 |
| 90 | Pustule (HP:0200039) | 2.23853275 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.22476693 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22476693 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.20319735 |
| 94 | Recurrent fungal infections (HP:0002841) | 2.19116745 |
| 95 | IgA deficiency (HP:0002720) | 2.17462932 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 2.13263662 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13121768 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13121768 |
| 99 | Deep venous thrombosis (HP:0002625) | 2.11416255 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.10907626 |
| 101 | Periodontitis (HP:0000704) | 2.10686572 |
| 102 | Neoplasm of the lung (HP:0100526) | 2.10483410 |
| 103 | Flat acetabular roof (HP:0003180) | 2.10477139 |
| 104 | Cerebral edema (HP:0002181) | 2.09674364 |
| 105 | Hypertensive crisis (HP:0100735) | 2.06516383 |
| 106 | Cholelithiasis (HP:0001081) | 2.05985143 |
| 107 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02123592 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.01504629 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 1.99811062 |
| 110 | Abnormality of renin-angiotensin system (HP:0000847) | 1.99768674 |
| 111 | Autoimmune thrombocytopenia (HP:0001973) | 1.99440677 |
| 112 | Macroorchidism (HP:0000053) | 1.99211734 |
| 113 | Hematochezia (HP:0002573) | 1.99024590 |
| 114 | Metabolic alkalosis (HP:0200114) | 1.96362187 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96229419 |
| 116 | Recurrent skin infections (HP:0001581) | 1.95829092 |
| 117 | Ankyloglossia (HP:0010296) | 1.94392811 |
| 118 | Alkalosis (HP:0001948) | 1.93784047 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 1.92407159 |
| 120 | Lymphopenia (HP:0001888) | 1.91788265 |
| 121 | Metaphyseal cupping (HP:0003021) | 1.91726241 |
| 122 | Fragile skin (HP:0001030) | 1.91338504 |
| 123 | Retrobulbar optic neuritis (HP:0100654) | 1.91257054 |
| 124 | Optic neuritis (HP:0100653) | 1.91257054 |
| 125 | Chest pain (HP:0100749) | 1.90574889 |
| 126 | Ileus (HP:0002595) | 1.89480494 |
| 127 | Hypermelanotic macule (HP:0001034) | 1.88664728 |
| 128 | Hepatocellular necrosis (HP:0001404) | 1.87486108 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.85888647 |
| 130 | Supranuclear gaze palsy (HP:0000605) | 1.85407689 |
| 131 | Abnormality of primary teeth (HP:0006481) | 1.85343895 |
| 132 | Pheochromocytoma (HP:0002666) | 1.84645608 |
| 133 | Increased IgM level (HP:0003496) | 1.84509127 |
| 134 | Skin ulcer (HP:0200042) | 1.83029822 |
| 135 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82160294 |
| 136 | Eosinophilia (HP:0001880) | 1.79901635 |
| 137 | Arthralgia (HP:0002829) | 1.72424516 |
| 138 | Colon cancer (HP:0003003) | 1.72422713 |
| 139 | Eczematoid dermatitis (HP:0000976) | 1.72155554 |
| 140 | Sensory axonal neuropathy (HP:0003390) | 1.71820265 |
| 141 | Purpura (HP:0000979) | 1.70867487 |
| 142 | Intrahepatic cholestasis (HP:0001406) | 1.70861254 |
| 143 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70538616 |
| 144 | Keratoconjunctivitis (HP:0001096) | 1.69771444 |
| 145 | Neuroendocrine neoplasm (HP:0100634) | 1.67614413 |
| 146 | Alacrima (HP:0000522) | 1.65982252 |
| 147 | Hepatic necrosis (HP:0002605) | 1.63737315 |
| 148 | Mitochondrial inheritance (HP:0001427) | 1.61799936 |
| 149 | Nasal polyposis (HP:0100582) | 1.59455261 |
| 150 | Xanthomatosis (HP:0000991) | 1.56861618 |
| 151 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.56434124 |
| 152 | Hyperbilirubinemia (HP:0002904) | 1.55653230 |
| 153 | Camptodactyly of toe (HP:0001836) | 1.54958606 |
| 154 | Prolonged partial thromboplastin time (HP:0003645) | 1.54559561 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.53863638 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.53863638 |
| 157 | Generalized myoclonic seizures (HP:0002123) | 1.53360390 |
| 158 | Cerebral hemorrhage (HP:0001342) | 1.52383668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.86876596 |
| 2 | ERN1 | 3.79420871 |
| 3 | MST1R | 3.33878756 |
| 4 | IRAK4 | 3.06023754 |
| 5 | PRPF4B | 2.97600428 |
| 6 | KIT | 2.88499955 |
| 7 | CSF1R | 2.66669672 |
| 8 | RIPK4 | 2.63399408 |
| 9 | RIPK1 | 2.59034888 |
| 10 | EPHA3 | 2.43079216 |
| 11 | GRK6 | 2.23536572 |
| 12 | SYK | 2.13330326 |
| 13 | FGFR2 | 1.99846745 |
| 14 | EPHB1 | 1.99054525 |
| 15 | MAP3K4 | 1.98805773 |
| 16 | SIK2 | 1.96196482 |
| 17 | MAP3K13 | 1.95125238 |
| 18 | FRK | 1.88801423 |
| 19 | FES | 1.88723623 |
| 20 | TYK2 | 1.85347372 |
| 21 | BCKDK | 1.84559464 |
| 22 | TBK1 | 1.81797074 |
| 23 | LYN | 1.71172979 |
| 24 | ADRBK2 | 1.67080932 |
| 25 | PIK3CA | 1.63873548 |
| 26 | PKN1 | 1.63250761 |
| 27 | MST4 | 1.61148503 |
| 28 | MAP3K14 | 1.59356648 |
| 29 | BMX | 1.56081836 |
| 30 | SIK1 | 1.51300708 |
| 31 | ZAP70 | 1.50076136 |
| 32 | NME2 | 1.46508296 |
| 33 | BUB1 | 1.45386331 |
| 34 | CLK1 | 1.44300481 |
| 35 | UHMK1 | 1.41672111 |
| 36 | BTK | 1.39027400 |
| 37 | ACVR1B | 1.36833460 |
| 38 | HIPK2 | 1.32500180 |
| 39 | MAP3K1 | 1.27895238 |
| 40 | PRKCH | 1.27322050 |
| 41 | NEK2 | 1.24768187 |
| 42 | PDGFRA | 1.23060339 |
| 43 | TNIK | 1.22817542 |
| 44 | STK24 | 1.22425137 |
| 45 | ITK | 1.19376509 |
| 46 | EPHA2 | 1.17294356 |
| 47 | IRAK3 | 1.16179229 |
| 48 | IRAK1 | 1.14512544 |
| 49 | PRKCQ | 1.12462436 |
| 50 | TTN | 1.12234304 |
| 51 | MET | 1.10774066 |
| 52 | FER | 1.09432760 |
| 53 | HCK | 1.06962262 |
| 54 | BLK | 1.03594455 |
| 55 | TRIB3 | 1.01860211 |
| 56 | PIK3CG | 1.01798949 |
| 57 | TXK | 1.01737798 |
| 58 | NLK | 1.01502732 |
| 59 | SMG1 | 0.94936494 |
| 60 | NEK1 | 0.94639038 |
| 61 | DDR2 | 0.92517799 |
| 62 | STK10 | 0.92288818 |
| 63 | JAK1 | 0.92271115 |
| 64 | CSNK1G3 | 0.91588799 |
| 65 | LCK | 0.89544254 |
| 66 | PTK6 | 0.85101588 |
| 67 | EIF2AK3 | 0.84226935 |
| 68 | PKN2 | 0.84082598 |
| 69 | IKBKE | 0.83888754 |
| 70 | YES1 | 0.83359322 |
| 71 | TAOK1 | 0.82971482 |
| 72 | MATK | 0.79917459 |
| 73 | IKBKB | 0.79791484 |
| 74 | CSNK1A1L | 0.79717514 |
| 75 | EPHB2 | 0.79001941 |
| 76 | KSR2 | 0.77037670 |
| 77 | RET | 0.75404379 |
| 78 | TGFBR2 | 0.74070931 |
| 79 | MAP3K3 | 0.73508903 |
| 80 | MYLK | 0.73378591 |
| 81 | NTRK3 | 0.72841659 |
| 82 | FGFR3 | 0.72753514 |
| 83 | PRKD1 | 0.72479515 |
| 84 | CSNK1G2 | 0.71245960 |
| 85 | FGR | 0.69479515 |
| 86 | MAPK7 | 0.66852451 |
| 87 | LMTK2 | 0.65201956 |
| 88 | ALK | 0.63757480 |
| 89 | MAP3K2 | 0.63495028 |
| 90 | MAPK12 | 0.61539737 |
| 91 | EPHA4 | 0.60978951 |
| 92 | PDPK1 | 0.60849590 |
| 93 | FYN | 0.60624288 |
| 94 | ROCK2 | 0.60441468 |
| 95 | DMPK | 0.59363441 |
| 96 | PRKCD | 0.59326450 |
| 97 | MAP3K6 | 0.59241181 |
| 98 | LRRK2 | 0.59065037 |
| 99 | CDC42BPA | 0.58497950 |
| 100 | MARK3 | 0.56055164 |
| 101 | MAPK13 | 0.56026171 |
| 102 | CSNK1G1 | 0.54416812 |
| 103 | PDGFRB | 0.53366276 |
| 104 | JAK3 | 0.53111804 |
| 105 | MAP2K3 | 0.52988862 |
| 106 | CDK6 | 0.52515151 |
| 107 | TGFBR1 | 0.51859409 |
| 108 | CSK | 0.51725146 |
| 109 | MAP3K9 | 0.50973733 |
| 110 | RPS6KA6 | 0.50788272 |
| 111 | ICK | 0.50072900 |
| 112 | RPS6KL1 | 0.49449623 |
| 113 | RPS6KC1 | 0.49449623 |
| 114 | NME1 | 0.49349092 |
| 115 | PIM1 | 0.49182572 |
| 116 | PRKG2 | 0.48493961 |
| 117 | EEF2K | 0.46150836 |
| 118 | NEK9 | 0.45971672 |
| 119 | MAPK11 | 0.45862103 |
| 120 | MINK1 | 0.45836065 |
| 121 | PAK3 | 0.45142337 |
| 122 | PAK4 | 0.45062664 |
| 123 | BMPR2 | 0.45023784 |
| 124 | STK39 | 0.44444731 |
| 125 | BRSK1 | 0.44139213 |
| 126 | OXSR1 | 0.43943082 |
| 127 | FGFR4 | 0.43683993 |
| 128 | CAMK2A | 0.41222025 |
| 129 | MAP3K10 | 0.40932325 |
| 130 | TESK2 | 0.39903091 |
| 131 | SIK3 | 0.39371604 |
| 132 | INSR | 0.38263609 |
| 133 | PDK1 | 0.38044720 |
| 134 | CDK5 | 0.36735732 |
| 135 | MAPKAPK2 | 0.36631140 |
| 136 | PRKCZ | 0.36546379 |
| 137 | BCR | 0.35933570 |
| 138 | JAK2 | 0.35555531 |
| 139 | MAP2K2 | 0.35070460 |
| 140 | IGF1R | 0.34932496 |
| 141 | TEC | 0.34129033 |
| 142 | GRK5 | 0.33840258 |
| 143 | ROCK1 | 0.33781984 |
| 144 | MAPK4 | 0.33053937 |
| 145 | SRC | 0.32456496 |
| 146 | ABL1 | 0.30834362 |
| 147 | TAOK2 | 0.30762047 |
| 148 | TAOK3 | 0.30580062 |
| 149 | TESK1 | 0.28435996 |
| 150 | PRKD2 | 0.26675637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.09141511 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.54551022 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.41832637 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.35062404 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.16991618 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.04242923 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02975850 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.49977988 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27599955 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.11508149 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.08088171 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80600641 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76453171 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.69766947 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69256564 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55211922 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55045621 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.49201162 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46639789 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.42622583 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42373136 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37892491 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34267676 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33786900 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.32764972 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29952218 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24789902 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.19313337 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18482084 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15268986 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14999208 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10274785 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09678812 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08694430 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06346107 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05889778 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05013878 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01474864 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.98759773 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 0.98412344 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97408338 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96996671 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96460122 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96375819 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96136086 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95765038 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 0.94249960 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92985253 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92477130 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91424827 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91327013 |
| 52 | Measles_Homo sapiens_hsa05162 | 0.90690156 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90260751 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87960486 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84323361 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.84280098 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84237679 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83887427 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82813535 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81455918 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80978939 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80826669 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80575859 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79978543 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79902827 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77427374 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.76662211 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74495602 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74392645 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74138473 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72733335 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71958509 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71052690 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.70844775 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70747984 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69802370 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.69703283 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69548225 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68042948 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67388136 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66925171 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65515431 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65151556 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64712655 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62874007 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62520632 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.62509882 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62394001 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62018567 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.61428892 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61381423 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60595485 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60109720 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59199104 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59118119 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57588524 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56759921 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56649563 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56199929 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55780093 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.55509499 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54939238 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54491135 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53291819 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53017657 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.52580191 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51253589 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50719410 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.49850612 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.49717904 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49507147 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49373757 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.49017897 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48948690 |
| 115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47960736 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47067617 |
| 117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46016086 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45312112 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.45089179 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44135149 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44079560 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.43956813 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42066330 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42029975 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41584392 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41499273 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41402498 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39051374 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38897089 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38496815 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37309297 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.36975293 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36741879 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34226515 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34046416 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33912462 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.33460022 |
| 138 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33313518 |
| 139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32901387 |
| 140 | Ribosome_Homo sapiens_hsa03010 | 0.32225465 |
| 141 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32002534 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31862668 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31794793 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31661445 |
| 145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31568654 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.30759008 |
| 147 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29939962 |
| 148 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29694956 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29356330 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29204588 |
| 151 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28881646 |
| 152 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28854927 |
| 153 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26464902 |
| 154 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25245921 |
| 155 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24010636 |
| 156 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23864138 |
| 157 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23805309 |

